The aminobisphosphonate alendronate inhibits bone loss induced by thyroid hormone in the rat comparison between effects on tibiae and vertebrae
- 30 June 1993
- Vol. 14 (3) , 499-504
- https://doi.org/10.1016/8756-3282(93)90186-e
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- On the rat model of human osteopenias and osteoporosesBone and Mineral, 1992
- The thyroid and osteoporosisTrends in Endocrinology & Metabolism, 1992
- Ipriflavone inhibits murine osteoclast formationIn VitroCalcified Tissue International, 1992
- Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancyBone, 1991
- Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responsesClinical Endocrinology, 1991
- Advances in the Management of Paget??s Disease of BoneDrugs, 1990
- Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineageJournal of Bone and Mineral Research, 1990
- Effects of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate on mouse osteoclastsJournal of Bone and Mineral Research, 1990
- Normal and Pathological Remodeling of Human Trabecular Bone: Three Dimensional Reconstruction of the Remodeling Sequence in Normals and in Metabolic Bone Disease*Endocrine Reviews, 1986
- Exogenous hyperthyroidism with osteoporosisArchives of internal medicine (1960), 1983